Search

everythinglearnresearchcommunity

for

Search:↓

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Detailed history and physical examination are crucial for diagnosing hair loss.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Gut flora changes could potentially indicate depression, but more research is needed.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.